
NKGen Biotech, Inc. (NKGN) Latest News & Updates
Explore latest NKGN News and Updates
Stay updated on NKGN with the latest news, market trends, and key developments to support informed investing decisions.
Start investing in NKGN
Order type
Buy in
Order amount
Est. shares
0 shares


NKGen Biotech's SNK01 NK Cell Therapy Cleared to Start Phase 2 Clinical Trial in Alzheimer's Disease
GlobeNewsWire •


GlobeNewsWire •


GlobeNewsWire •


NKGen Biotech Secures Additional Financing of $5 Million to Continue Advancing Its Clinical Programs
GlobeNewsWire •

GlobeNewsWire •

InvestorPlace •

GlobeNewsWire •


GlobeNewsWire •

GlobeNewsWire •

GlobeNewsWire •

GlobeNewsWire •

GlobeNewsWire •

GlobeNewsWire •

GlobeNewsWire •


- 1
- 2